Meningioma A071401
Study #A071401Phase II Trial of SMO / AKT / NF2 / CDK Inhibitors in Progressive Meningiomas with SMO / AKT / NF2 / CDK Pathway Mutations
Back To Clinical Trials NCI Database Entry
Phase II Trial of SMO / AKT / NF2 / CDK Inhibitors in Progressive Meningiomas with SMO / AKT / NF2 / CDK Pathway Mutations
Back To Clinical Trials NCI Database Entry